JPS5929691A - Purification of 5-methyl-7-diethylamino-s-triazolo(1,5-a) pyrimidine - Google Patents

Purification of 5-methyl-7-diethylamino-s-triazolo(1,5-a) pyrimidine

Info

Publication number
JPS5929691A
JPS5929691A JP13796482A JP13796482A JPS5929691A JP S5929691 A JPS5929691 A JP S5929691A JP 13796482 A JP13796482 A JP 13796482A JP 13796482 A JP13796482 A JP 13796482A JP S5929691 A JPS5929691 A JP S5929691A
Authority
JP
Japan
Prior art keywords
trapidil
crude
sulfur compound
contact
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13796482A
Other languages
Japanese (ja)
Other versions
JPH0237358B2 (en
Inventor
Shigeru Isayama
諌山 滋
Teijiro Morimoto
森本 悌次郎
Shigeji Shimizu
清水 茂二
Noriaki Kihara
木原 則昭
Tatsukazu Ishida
石田 達麗
Onori Fukuoka
大典 福岡
Taira Harada
原田 平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Petrochemical Industries Ltd
Original Assignee
Mitsui Petrochemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Petrochemical Industries Ltd filed Critical Mitsui Petrochemical Industries Ltd
Priority to JP13796482A priority Critical patent/JPH0237358B2/en
Publication of JPS5929691A publication Critical patent/JPS5929691A/en
Publication of JPH0237358B2 publication Critical patent/JPH0237358B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To prepare 5-methyl-7-diethylamino-s-triazolo[1,5-a]pyridine(trapidil for short) useful as a coronary vasodilator, having high purity and high quality, by bringing crude trapidil into contact with a sulfur compound having a reducing action. CONSTITUTION:Crude trapidil is brought into contact with a sulfur compound (e.g., 5-20wt% NaHSO3, Na2SO3, etc. is preferably used) having reducing action in the presence of preferably 20-100 times as much water as the sulfur compound by weight, to purify trapidil. Crude trapidil is used as an aqueous solution, and the contact of it with the sulfur compound is carried out preferably at 20- 90 deg.C for 1.0-6hr.

Description

【発明の詳細な説明】 本発明は、5−メチル−7−ダニチルアミノ−8−トリ
アゾロ(1,5−a)ピリミジン(以下、トラピジルと
略称する。)の精製方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for purifying 5-methyl-7-danitylamino-8-triazolo(1,5-a)pyrimidine (hereinafter abbreviated as trapidil).

トラピジルは冠拡張剤として優れた薬効を有することが
知られている。このトラピジルを製造する方法は、例え
ば英国特許第1148629号、特開昭56−79’6
74号、特開昭56−108772号などの公報明細書
に提案されている。またこれらの先行技術文献には、粗
製のトラピジルを各種の溶剤を用いて、抽出、再結晶な
どの諸操作を繰り返すことによって精製しようとする試
みも記載されている。しかしながら、これらに具体的に
開示されている方法によっても粗製のトラピジルは充分
には精製されず、例えば得られるトラピジルが着色不純
物で汚染されていたり、あるいは充分に純度が高くなく
、医薬品として供するには不充分な品質であることが多
い。
Trapidil is known to have excellent medicinal efficacy as a coronary dilator. This method for producing trapidil is described, for example, in British Patent No. 1148629 and Japanese Patent Application Laid-open No. 56-79'6.
This method has been proposed in publications such as No. 74 and Japanese Unexamined Patent Publication No. 56-108772. These prior art documents also describe attempts to purify crude trapidil by repeating various operations such as extraction and recrystallization using various solvents. However, even by the methods specifically disclosed in these publications, crude trapidil is not purified sufficiently, and for example, the resulting trapidil is contaminated with colored impurities or is not sufficiently pure to be used as a pharmaceutical product. are often of insufficient quality.

本発明者らは、これらの現状に鑑み、粗製のトラピジル
から医薬品として適合し得る高品質でかつ高純度の精製
品を収率よく得る方法について鋭意検討を重ねた結果、
精製のトラピジルを特定の硫黄化合物で接触処理するこ
とにより前記目的を達成できることを見出し、本発明の
方法に到達したものである。
In view of these current circumstances, the present inventors have conducted intensive studies on a method for obtaining high-quality, highly purified purified products suitable for use as pharmaceuticals from crude trapidil in good yield.
The inventors have discovered that the above object can be achieved by contacting purified trapidil with a specific sulfur compound, and have arrived at the method of the present invention.

本発明を概説すれば、本発明は、粗製のトラピジルと還
元作用を有する硫黄化合物とを、水の存在下に接触させ
ることを特徴とする該化合物の精積法、を要旨とするも
のである。
To summarize the present invention, the gist of the present invention is a method for distilling crude trapidil and a sulfur compound having a reducing action, which is characterized by contacting the compound in the presence of water. .

もよい。例えば7位がハロゲン、メルカプト基、アルキ
ルメルカプト基、アルコキシル基等で置換された5−メ
チル−7−置換−5−)リアゾロ(1,5−a)ピリミ
ジンとジエチルアミンを反応させる方法、N、N−ジエ
チル酢酸アミドと6−アミノ−1,2,4−トリアゾー
ルを脱水剤の存在下で反応させる方法3−ハロ(または
アルコキシ)クロトン酸ジエチルアミ ドと3−アミノ
−1,2,4−)リアゾロールを縮合剤の存在下で反応
させる方法などを例示することができるが、本発明の方
法は、これらの方法に特定されない。
Good too. For example, a method of reacting diethylamine with 5-methyl-7-substituted-5-)riazolo(1,5-a)pyrimidine in which the 7-position is substituted with a halogen, mercapto group, alkylmercapto group, alkoxyl group, etc., N,N -Method of reacting diethyl acetate amide and 6-amino-1,2,4-triazole in the presence of a dehydrating agent 3-Halo(or alkoxy)crotonic acid diethylamide and 3-amino-1,2,4-)riazolole The method of the present invention is not limited to these methods, but the method of the present invention is not limited to these methods.

本発明の方法において、使用される還元作用を有する硫
黄化合物として具体的には、Na2S1Na2S2、N
aH8,NaH3O6、Na2SO3、Na2S2O4
、Na S OZn(H’5O3)、およびロンガリッ
トCなど 23X を例示することができる。これらの硫黄化合物のうちで
は、NaH3O6、Na25o5などの金属亜硫酸塩化
合物を使用すると精製効果が著しいので好適である。こ
れらの硫黄化合物の使用量は粗製のトラピジルに対して
通常1〜50重量%、好ましくは5〜20重量%の範囲
である。
In the method of the present invention, specifically, the sulfur compounds having a reducing action used include Na2S1Na2S2, N
aH8, NaH3O6, Na2SO3, Na2S2O4
, Na S OZn (H'5O3), and Rongalit C. 23X can be exemplified. Among these sulfur compounds, it is preferable to use metal sulfite compounds such as NaH3O6 and Na25o5 because they have a remarkable purification effect. The amount of these sulfur compounds used is usually 1 to 50% by weight, preferably 5 to 20% by weight based on crude trapidil.

本発明の方法において、前記粗製トラピジルと前記硫黄
化合物との接触処理は水の存在下に実施することが必要
である。その接触の際の水の存在割合は、前記硫黄化合
物に対して通常5ないし200重量倍、好ましくは20
ないし100重量倍の範囲であり、前記硫黄化合物が溶
解する量であることが好適である。もちろん、前記粗製
トラピジルを水溶液または水含有溶液の形態で使用した
場合には、改めて水を加えることは必ずしも必要でない
In the method of the present invention, it is necessary to carry out the contact treatment of the crude trapidil and the sulfur compound in the presence of water. The proportion of water present during the contact is usually 5 to 200 times the weight of the sulfur compound, preferably 20 times the weight of the sulfur compound.
The amount ranges from 100 to 100 times by weight, and the amount is preferably such that the sulfur compound is dissolved. Of course, when the crude trapidil is used in the form of an aqueous solution or a water-containing solution, it is not necessarily necessary to add water again.

本発明の方法において、前記粗製トラピジルと前記硫黄
化合物とを接触させる際には、該粗製のトラピジルは溶
液状態であることが好適であり、水溶液の状態であって
もよいし、還元作用を有する硫黄化合物に対して不活性
な有機溶媒の溶液の状態であってもよいが、水溶液の状
態であること6− がとくに好ましい。該粗製のトラピジルを前記有機溶媒
溶液の形態で使用する際には、該溶液は非水溶性溶媒の
溶液であることが好ましい。
In the method of the present invention, when the crude trapidil and the sulfur compound are brought into contact with each other, the crude trapidil is preferably in a solution state, and may be in an aqueous solution state, and has a reducing action. Although it may be in the form of a solution of an organic solvent inert to sulfur compounds, it is particularly preferable that it be in the form of an aqueous solution. When the crude trapidil is used in the form of a solution in the organic solvent, the solution is preferably a solution in a non-aqueous solvent.

有機溶媒として具体的には、ヘキサン、ベンゼン、トル
エン、キシレンナトの炭化水素、クロロホルム、エチレ
ンジクロライドなどのハロゲン化炭化水素、メタノール
、エタノールなどのアルコールあるいは二硫化炭素など
の広範囲の溶媒を例示することができる。これらの溶媒
は、2種以上の混合溶媒として使用することもできる。
Specific examples of organic solvents include a wide range of solvents such as hydrocarbons such as hexane, benzene, toluene, and xylene, halogenated hydrocarbons such as chloroform and ethylene dichloride, alcohols such as methanol and ethanol, and carbon disulfide. can. These solvents can also be used as a mixed solvent of two or more.

本発明の方法において、前記粗製のトラピジルの溶液、
前記硫黄化合物、水および必要に応じて溶媒からなる混
合物は、通常攪拌または振とう条件下に接触させられる
。接触処理の際の温度はとくに限定されないが、通常1
0°Cないし150℃、好ましくは20℃ないし90°
Cの範囲である。接触処理の際の時間は使用する硫黄化
合物の種類および温度によって異なるが、通常は0.5
ないし30時間、好ましくは1,0ないし6時間の範囲
で充分の精製効果を挙げることができる。
In the method of the present invention, a solution of the crude trapidil,
The mixture of the sulfur compound, water, and optionally a solvent is usually brought into contact under stirring or shaking conditions. The temperature during contact treatment is not particularly limited, but is usually 1.
0°C to 150°C, preferably 20°C to 90°
It is in the range of C. The time for contact treatment varies depending on the type of sulfur compound used and the temperature, but is usually 0.5
A sufficient purification effect can be obtained within a range of from 1.0 to 30 hours, preferably from 1.0 to 6 hours.

4一 本発明の方法によれば、硫黄化合物と接触させた後の混
合物に通常の抽出、晶析操作を施すことによって医薬品
として適合し得る着色度の少ない高品質、かつ高純度の
トラピジルを得ることができるO 次に実施例により本発明を具体的に説明する。
41 According to the method of the present invention, by subjecting the mixture to contact with a sulfur compound and subjecting it to conventional extraction and crystallization operations, trapidil of high quality and purity with a low degree of coloring and suitable for use as a pharmaceutical product can be obtained. Next, the present invention will be specifically explained with reference to Examples.

なお、実施例に示したトラピジルの吸光度4(450n
m)は、1cInのセルを用いたトラピジルの1重量%
水溶液の波長450nmでの吸光度を0.667% 表わし、K    (427nm)は1画のセルを用い
た1α トラピジルの0.667重量%水溶液の波長427nm
での吸光度である。
In addition, the absorbance of trapidil shown in the example is 4 (450n
m) is 1% by weight of trapidil using a 1 cIn cell.
The absorbance of an aqueous solution at a wavelength of 450 nm is 0.667%, and K (427 nm) is 1α using a one-stroke cell.The wavelength of a 0.667% by weight aqueous solution of trapidil is 427 nm.
This is the absorbance at

5−メチル−7−ヒドロキシ−8−トリアゾロ〔1,5
−a)ピリミジン300.8 gとエチレンジクロライ
ド750gおよびオキシ塩化リン636gを窒素気流下
に90°C〜88℃で5時間加熱攪拌した。この溶液を
水1400gと重炭酸ナトリウム840gの混合物に2
0°Cで滴下して、同温度でさらに1.0時間攪拌した
。この反応混合物にクロロホルムドア00gを加えて有
機層と水層とに分液した。有機層にジエチルアミン32
2gを30’Cで滴下して、滴下終了後5゜°Cで1.
0時間攪拌した。次いでこの反応混合物を水500gで
洗浄して有機層を乾固したところ粗製のトラピジルが6
21g得られた(純度95.8%〕。
5-methyl-7-hydroxy-8-triazolo[1,5
-a) 300.8 g of pyrimidine, 750 g of ethylene dichloride, and 636 g of phosphorus oxychloride were heated and stirred at 90° C. to 88° C. for 5 hours under a nitrogen stream. Add this solution to a mixture of 1400 g water and 840 g sodium bicarbonate for 2 hours.
The mixture was added dropwise at 0°C and further stirred at the same temperature for 1.0 hour. 00 g of chloroform door was added to this reaction mixture to separate it into an organic layer and an aqueous layer. Diethylamine 32 in the organic layer
2g was dropped at 30'C, and after the dropping was completed, it was heated to 5°C for 1.
Stirred for 0 hours. Next, this reaction mixture was washed with 500 g of water and the organic layer was dried to give 6.0 g of crude trapidil.
21g was obtained (purity 95.8%).

これはトラピジルの収率75%に相当する。This corresponds to a yield of trapidil of 75%.

\ 実施例1 粗製のトラピジル(4(450:nm)11.611、
純度95.8%) 5.C1gをキシレン20gに溶解
させてNaH3O,,0,5gを含む水溶液5.0gを
加え、80’Cで1.0時間攪拌し、キシレン層からキ
シレンを留去したところ純度98%のトラピジルが4.
9g得られ、このトラピジルの吸光度’l!(450n
m)は0.320であった。
\ Example 1 Crude trapidil (4 (450: nm) 11.611,
Purity 95.8%) 5. 1 g of C was dissolved in 20 g of xylene, 5.0 g of an aqueous solution containing 0.5 g of NaH3O was added, the mixture was stirred at 80'C for 1.0 hour, and the xylene was distilled off from the xylene layer, resulting in 4 trapidil with a purity of 98%. ..
9g was obtained, and the absorbance of this trapidil was 'l! (450n
m) was 0.320.

比較例1 実施例1においてNaH8O3を加えることな〈実施例
1と同様の操作を行った。その結果、純度98%のトラ
ピジルが4.75 g得られ、その吸光度E4(450
nm)は0.600であった。
Comparative Example 1 The same operation as in Example 1 was performed except that NaH8O3 was not added. As a result, 4.75 g of trapidil with a purity of 98% was obtained, and its absorbance was E4 (450
nm) was 0.600.

実施例2〜9 表1に示した吸光度の粗製トラピジル50gを水100
gに溶解した。この溶液に表1に示した種々の硫黄化合
物5gを加えて表1に示した温度で6時間攪拌したのち
、この溶液の吸光度を測定したところ表1の結果が得ら
れた。
Examples 2 to 9 50 g of crude trapidil having the absorbance shown in Table 1 was added to 100 g of water.
Dissolved in g. After adding 5 g of the various sulfur compounds shown in Table 1 to this solution and stirring at the temperature shown in Table 1 for 6 hours, the absorbance of this solution was measured, and the results shown in Table 1 were obtained.

7− 表1.硫黄化合物と処理後の吸光度 実施例10 粗製のトラピジル(w OA、67%(427nm)1
.00)50gを100gの水に溶解させてNaH8O
35,0gを加え、80°Cで5.0時間攪拌したとこ
ろこの溶液の吸光度E?(M″%(4271m)は0.
220に減じた。
7- Table 1. Absorbance after treatment with sulfur compounds Example 10 Crude trapidil (w OA, 67% (427 nm) 1
.. 00) Dissolve 50g in 100g of water to make NaH8O
When 35.0 g of the solution was added and stirred at 80°C for 5.0 hours, the absorbance of this solution was E? (M″% (4271m) is 0.
It was reduced to 220.

次いでキシレン200gを加えて80’Cで抽出した。Then, 200 g of xylene was added and extracted at 80'C.

キシレン層からキシレンを150g留去して残りの8− 溶液からトラピジルを晶析させたところ、無色の結晶と
してトラピジルが52g得られた。このものの純度は9
9,2%であり吸光度”’;:AC427nm)は0.
030であった。
When 150 g of xylene was distilled off from the xylene layer and trapidil was crystallized from the remaining 8-solution, 52 g of trapidil was obtained as colorless crystals. The purity of this thing is 9
9.2%, and the absorbance (at AC427nm) is 0.
It was 030.

出願人  三井石油化学工業株式会社 代理人  山  口     和Applicant: Mitsui Petrochemical Industries, Ltd. Agent Kazu Yamaguchi

Claims (1)

【特許請求の範囲】[Claims] (1)  粗製の5−メチル−7−ダニチルアミノ−8
−トリアゾロ(1,5−a)ピリミジンと還元作用を有
する硫黄化合物とを、水の存在下に接触させることを特
徴とする該化合物の精製法0
(1) Crude 5-methyl-7-danitylamino-8
- A method for purifying a triazolo(1,5-a)pyrimidine and a sulfur compound having a reducing action in the presence of water 0
JP13796482A 1982-08-10 1982-08-10 55MECHIRUU77JECHIRUAMINOOSSTORIAZORO * 1 * 55A * PIRIMIJINNOSEISEIHO Expired - Lifetime JPH0237358B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13796482A JPH0237358B2 (en) 1982-08-10 1982-08-10 55MECHIRUU77JECHIRUAMINOOSSTORIAZORO * 1 * 55A * PIRIMIJINNOSEISEIHO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13796482A JPH0237358B2 (en) 1982-08-10 1982-08-10 55MECHIRUU77JECHIRUAMINOOSSTORIAZORO * 1 * 55A * PIRIMIJINNOSEISEIHO

Publications (2)

Publication Number Publication Date
JPS5929691A true JPS5929691A (en) 1984-02-16
JPH0237358B2 JPH0237358B2 (en) 1990-08-23

Family

ID=15210841

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13796482A Expired - Lifetime JPH0237358B2 (en) 1982-08-10 1982-08-10 55MECHIRUU77JECHIRUAMINOOSSTORIAZORO * 1 * 55A * PIRIMIJINNOSEISEIHO

Country Status (1)

Country Link
JP (1) JPH0237358B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02182955A (en) * 1988-12-28 1990-07-17 Three D Konpo Res:Kk Unit for regulating cloth fell of machine for weaving three-dimensional fabric
CN107056787A (en) * 2016-12-29 2017-08-18 大桐制药(中国)有限责任公司 The synthesis technique of trapidil

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02182955A (en) * 1988-12-28 1990-07-17 Three D Konpo Res:Kk Unit for regulating cloth fell of machine for weaving three-dimensional fabric
JPH0413465B2 (en) * 1988-12-28 1992-03-09 Three D Composite Res Kk
CN107056787A (en) * 2016-12-29 2017-08-18 大桐制药(中国)有限责任公司 The synthesis technique of trapidil

Also Published As

Publication number Publication date
JPH0237358B2 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
JPH0329791B2 (en)
EP0096297B1 (en) Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
EP0508234B1 (en) Beta-lactames
JP2021514371A (en) Method for Producing Prostaglandin Analogs That Donate Nitric Oxide
JP2000514090A (en) Purification method
LU86540A1 (en) CEPHALOSPORIN SALTS AND INJECTABLE COMPOSITIONS
US6114541A (en) Method for the preparation of α-Bromo-Lactam derivatives
EP1273586A1 (en) Penicillin crystal and process for producing the same
JPS5929691A (en) Purification of 5-methyl-7-diethylamino-s-triazolo(1,5-a) pyrimidine
CA1219587A (en) Hydroxybenzylaminobenzenes as anti-inflammatory agents
JP4540568B2 (en) Method for producing L-carnosine
EP1138674A1 (en) Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
JP3793583B2 (en) Antibacterial compound crystals
TW202241390A (en) Process for the preparation of a nitric oxide donating prostaglandin analogue
EP0975607A1 (en) A process for the preparation of highly pure 6,7-dichloro-5- nitro-2,3-dihydroquinoxaline-2,3-dione
EP0234971A1 (en) Substituted amides, their preparation and pharmaceutical compositions containing them
JPH08505410A (en) 2-Alkoxy-4-hydrazinopyrimidine compounds and their use in the preparation of 5-alkoxy-1,2,4-triazolo [4,3-c pyrimidine-3 (2H) -thione compounds
KR100325558B1 (en) Method for Purifying 7-chloroquinoline-8-carboxylic Acid
JPS5939896A (en) Purification of 5-methyl-7-diethylamino-s-triazolo (1,5-a) pyrimidine
NZ204930A (en) Crystalline sodium cefoperazone and its preparation
JPH0770126A (en) Method for removing silyl group of silyl ether compound
JPS60158182A (en) Manufacture of substituted quinazoline- 2,4(1h,3h)-diones
JPS5929689A (en) Purification of 5-methyl-7-diethylamino-s-triazolo(1,5-a) pyrimidine
JPH0586042A (en) Process for producing 2-mercapto-phenothiazine
HU189645B (en) Improved process for preparing thio-bis-carbamate derivatives